Published in Eur J Cardiothorac Surg on January 01, 1990
Gastroepiploic artery free graft for coronary bypass. Eur J Cardiothorac Surg (1990) 1.38
The Right Gastroepiploic Artery Graft for Coronary Artery Bypass Grafting: A 30-Year Experience. Korean J Thorac Cardiovasc Surg (2016) 0.75
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science (1990) 3.74
An immunoendocrinological hypothesis of HIV infection. Lancet (1994) 2.19
Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest (1994) 2.01
pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc (2001) 1.74
Selectins: a family of adhesion receptors. Cell (1991) 1.72
A2A-adenosine receptor reserve for coronary vasodilation. Circulation (1998) 1.55
Mesothelioma and non-occupational environmental exposure to asbestos. Lancet (1991) 1.50
From endothelial dysfunction to atherosclerosis. Autoimmun Rev (2010) 1.47
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg (1995) 1.45
The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther (1998) 1.40
Post transfusion hepatitis: comparison between homologous and autologous blood transfusion. Eur J Med (1992) 1.39
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. J Pharmacol Exp Ther (1996) 1.30
Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents. Inorg Chem (2000) 1.28
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis (2011) 1.25
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med (2000) 1.24
Structural variations across the lanthanide series of macrocyclic DOTA complexes: insights into the design of contrast agents for magnetic resonance imaging. Inorg Chem (2003) 1.22
ATP-competitive inhibitors of mTOR: an update. Curr Med Chem (2011) 1.21
A cohort study on mortality among wives of workers in the asbestos cement industry in Casale Monferrato, Italy. Br J Ind Med (1993) 1.17
Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol (1991) 1.15
Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes. J Am Chem Soc (2001) 1.14
Antiangiogenic agents: an update on small molecule VEGFR inhibitors. Curr Med Chem (2007) 1.12
Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy. Occup Environ Med (1995) 1.11
Peptide sequencing by using a combination of partial acid hydrolysis and fast-atom-bombardment mass spectrometry. Biochem J (1986) 1.10
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Ann Oncol (2007) 1.09
Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI. J Biol Inorg Chem (2000) 1.09
The anti-inflammatory drug nimesulide rescues alpha-1-proteinase inhibitor from oxidative inactivation by phagocytosing neutrophils. Respiration (1992) 1.08
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab (1979) 1.06
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies. Biophys Chem (1998) 1.06
Selective adenosine A2A receptor antagonists. Farmaco (2001) 1.05
The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol (1999) 1.05
[Mortality from tumors and other diseases of the respiratory system in cement-asbestos workers in Casale Monferrato. A historical cohort study]. Med Lav (1988) 1.04
Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol (2001) 1.03
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. J Med Chem (2000) 1.03
Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes (1978) 1.03
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy. Magn Reson Med (1996) 1.03
High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int (1999) 1.02
Plasma-prolactin and cimetidine. Lancet (1977) 1.02
Skeletal muscle oxidative capacity in rats fed high-fat diet. Int J Obes Relat Metab Disord (2002) 1.02
Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol (2000) 1.01
Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice. Br J Pharmacol (2007) 0.98
[Subaortic hypertrophic stenosis associated with mitral insufficiency. Surgical treatment and report on an operated case]. G Ital Cardiol (1972) 0.97
Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward alpha(1)- and alpha(2)-adrenoceptors. J Med Chem (2001) 0.97
New insights into small-molecule inhibitors of Bcr-Abl. Med Res Rev (2011) 0.97
Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors. Curr Med Chem (2006) 0.96
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study. Int J Immunopathol Pharmacol (2009) 0.95
RRE: a tool for the extraction of non-coding regions surrounding annotated genes from genomic datasets. Bioinformatics (2004) 0.95
[Antioxidant action of gabexate mesilate (Foy) in an experimental model of endotoxic shock]. Minerva Anestesiol (1995) 0.95
Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes. Circ Res (1996) 0.94
A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone. Org Lett (1999) 0.94
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation. Bioorg Med Chem Lett (2004) 0.94
Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ Res (1989) 0.94
[GdPCP2A(H(2)O)(2)](-): a paramagnetic contrast agent designed for improved applications in magnetic resonance imaging. J Med Chem (2000) 0.94
[Tumor mortality and from other causes in asbestos cement workers at the Casale Montferrato plant]]. Med Lav (1996) 0.94
Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) (2006) 0.93
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J Med Chem (1994) 0.93
Gd(DOTP)5-outer-sphere relaxation enhancement promoted by nitrogen bases. Magn Reson Med (1993) 0.93
Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol (1995) 0.93
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart (2004) 0.93
Pleural malignant mesothelioma and environmental asbestos exposure in Casale Monferrato, Piedmont. Preliminary analysis of a case-control study. Med Lav (1998) 0.92
University of Wisconsin solution and human saphenous vein graft preservation: preliminary anatomic report. Eur J Cardiothorac Surg (1993) 0.92
Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication. Curr Med Chem (2011) 0.92
Fyn kinase in brain diseases and cancer: the search for inhibitors. Curr Med Chem (2011) 0.92
Tilted implants in the immediate loading rehabilitation of the maxilla: a systematic review. J Dent Res (2012) 0.91
Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: a new hereditary renal tubular-pituitary syndrome? Pediatr Res (1999) 0.91
Metoclopramide increases plasma aldosterone concentration in man. J Clin Endocrinol Metab (1977) 0.91
Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study. Occup Environ Med (1998) 0.90
Within-patient variability of hormone and cytokine concentrations in heart failure. Pharmacol Res (1998) 0.90
Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin Exp Rheumatol (1997) 0.90
Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr (1990) 0.89
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma. Br J Cancer (2013) 0.89
Prevalence of left-sided obstructive lesions in patients with atrioventricular canal without Down's syndrome. J Thorac Cardiovasc Surg (1986) 0.89
Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects. J Pharmacol Exp Ther (1994) 0.89
Cardiac catheterization through the internal jugular vein in pediatric patients. An alternative to the usual femoral vein access. Chest (1992) 0.88
Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant (1994) 0.88
Cardiac surgery in HIV-positive intravenous drug addicts: influence of cardiopulmonary bypass on the progression to AIDS. Thorac Cardiovasc Surg (1992) 0.88
Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1996) 0.88
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.88
Building a pharmacophore model for a novel class of antitubercular compounds. Farmaco (2001) 0.88
Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab (1992) 0.87
Inhibition of pig liver and Zea mays L. polyamine oxidase: a comparative study. J Enzyme Inhib (2001) 0.87
Fibrin adhesive: clinical application in coronary artery bypass graft surgery. Tex Heart Inst J (1985) 0.86
Role of A2A receptor in the modulation of myocardial reperfusion damage. J Cardiovasc Pharmacol (1999) 0.86
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. Lung Cancer (2001) 0.86
Pure Autonomic Failure: complex abnormalities in the neural mechanisms regulating the cardiovascular system. J Auton Nerv Syst (1995) 0.86
Hybrid aortic arch repair procedure: reinforcement of the aorta for a safe and durable landing zone. Eur J Vasc Endovasc Surg (2010) 0.86
New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization. Oncogene (2011) 0.86
Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma. Leuk Lymphoma (2002) 0.86
Disturbances in pulmonary gaseous exchange in primary hyperlipoproteinemias. Bull Eur Physiopathol Respir (1977) 0.86
A new class of nitric oxide-releasing derivatives of cetirizine; pharmacological profile in vascular and airway smooth muscle preparations. Br J Pharmacol (2007) 0.85
Long-term effects of spinal cord stimulation on myocardial ischemia and heart rate variability: results of a 48-hour ambulatory electrocardiographic monitoring. Ital Heart J (2001) 0.85
A1 receptors ligands: past, present and future trends. Curr Top Med Chem (2010) 0.85
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. J Endocrinol Invest (2007) 0.85
Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety. Bioconjug Chem (1999) 0.85
[Pelvic floor dyssynergia: videoproctographic analysis and pathologic associations in defecation obstruction syndrome]. Radiol Med (1998) 0.85
Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol (1995) 0.84